- Home
- SUPN vs IQ Comparison
SUPN vs IQ Comparison
Compare SUPN & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- IQ
- Stock Information
- Founded
- SUPN 2005
- IQ 2009
- Country
- SUPN United States
- IQ China
- Employees
- SUPN N/A
- IQ N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- IQ Consumer Electronics/Video Chains
- Sector
- SUPN Health Care
- IQ Consumer Discretionary
- Exchange
- SUPN Nasdaq
- IQ Nasdaq
- Market Cap
- SUPN 2.6B
- IQ 2.2B
- IPO Year
- SUPN 2012
- IQ 2018
- Fundamental
- Price
- SUPN $46.21
- IQ $2.58
- Analyst Decision
- SUPN Buy
- IQ Strong Buy
- Analyst Count
- SUPN 2
- IQ 5
- Target Price
- SUPN $43.00
- IQ $2.61
- AVG Volume (30 Days)
- SUPN 707.2K
- IQ 30.4M
- Earning Date
- SUPN 11-03-2025
- IQ 08-20-2025
- Dividend Yield
- SUPN N/A
- IQ N/A
- EPS Growth
- SUPN 1411.53
- IQ N/A
- EPS
- SUPN 1.14
- IQ 0.01
- Revenue
- SUPN $665,125,000.00
- IQ $3,863,007,761.00
- Revenue This Year
- SUPN $4.84
- IQ N/A
- Revenue Next Year
- SUPN $17.69
- IQ $3.79
- P/E Ratio
- SUPN $40.24
- IQ $296.75
- Revenue Growth
- SUPN 5.55
- IQ N/A
- 52 Week Low
- SUPN $29.16
- IQ $1.50
- 52 Week High
- SUPN $46.79
- IQ $3.35
- Technical
- Relative Strength Index (RSI)
- SUPN 73.71
- IQ 61.93
- Support Level
- SUPN $44.10
- IQ $2.70
- Resistance Level
- SUPN $46.79
- IQ $2.77
- Average True Range (ATR)
- SUPN 1.06
- IQ 0.13
- MACD
- SUPN -0.17
- IQ 0.01
- Stochastic Oscillator
- SUPN 85.92
- IQ 52.25
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.